CC Pharma Nordic ApS: Financial statements 2023
CVR: 39461528
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CC Pharma Nordic ApS (CVR 39461528) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025. The company had 1 employee in the financial year.
- Gross Profit
- DKK -215,055
- Profit/Loss
- DKK -807,857
- Equity
- DKK -7,707,025
- Total Assets
- DKK 503,921
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -215 t. | -808 t. | -7.7 mio. | 1 |
| 2022 | - | -1.6 mio. | -2.7 mio. | -7 mio. | 1 |
| 2021 | - | -910 t. | -2.5 mio. | -4.2 mio. | 1 |
| 2020 | - | 121 t. | -589 t. | -1.7 mio. | 1 |
| 2019 | - | -194 t. | -831 t. | -1.1 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 29, 2023, Bo Tandrup has left the board of directors of CC Pharma Nordic ApS.
As of November 29, 2023, Mathias Bernd Bossen is registered as chairman of CC Pharma Nordic ApS.
As of November 29, 2023, Klaus Herbert Becker has stepped down as chairman of CC Pharma Nordic ApS.
As of June 30, 2023, Alois Schmid has left the board of directors of CC Pharma Nordic ApS.
CC Pharma Nordic ApS has published its annual report for 2022. Gross profit came to DKK -1,634,362, and the net result was DKK -2,730,659.
As of January 23, 2023, Manfred Rolf Ziegler has left the board of directors of CC Pharma Nordic ApS.
About CC Pharma Nordic ApS
CC Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 7 January 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Astea Pharma ApS. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025.